ISMP Awarded Contract from FDA to Conduct Medication Safety Self-Assessment

The Institute for Safe Medication Practices (ISMP) has been awarded a contract from the FDA to assess medication safety practices in the perioperative setting from the time patients are prepared for a procedure until they are discharged home.

The Institute for Safe Medication Practices (ISMP) has been awarded a contract from the FDA to assess medication safety practices in the perioperative setting from the time patients are prepared for a procedure until they are discharged home.

The Medication Safety Self-Assessment for Perioperative Settings will assist health care practitioners in hospitals, ambulatory surgery centers, and other surgical sites in protecting patients from possible perioperative medication errors.

Due to the complexity and fast-paced setting of perioperative care procedures, ISMP’s Medication Safety Self-Assessment for Perioperative Settings will provide facilities with a way to examine their medication safety practices, identify opportunities for improvement, and compare their experiences over time with the aggregate experience of demographically similar organizations.

In addition, the new self-assessment will help participants document compliance with The Joint Commission’s requirement for conducting a proactive risk assessment on a high-volume, high-risk, or problem-prone process. The assessment will also assist the Centers for Medicare & Medicaid Services’ requirement for developing a data-driven quality assessment and performance improvement program.

The Medication Safety Self-Assessment is set to launch in September 2020, allowing participants to have unlimited opportunity to access, view, and download their own scores throughout the period of data collection.

REFERENCE

ISMP awarded contract to conduct perioperative medication safety self-assessment [news release]. Horsham, PA; Institute for Safe Medication Practices: March 12, 2020 [email]. Accessed March 12, 2020.